HAL


Summary: Histidine ammonia-lyase is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. Histidine ammonia-lyase defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluids. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
histidine ammonia-lyaseMIM:609457Ensembl:ENSG00000084110HGNC:HGNC:4806PA2918112q23.1

GO terms in HAL


Term TypeEvidence TypeGO Term IDGO Des.
MFEXPGO:0004397histidine ammonia-lyase activity
MFIBAGO:0004397histidine ammonia-lyase activity
MFIBAGO:0016841ammonia-lyase activity
CCTASGO:0005829cytosol
BPIBAGO:0006548histidine catabolic process
BPTASGO:0006548histidine catabolic process
BPIEAGO:0019556histidine catabolic process to glutamate and formamide
BPIEAGO:0019557histidine catabolic process to glutamate and formate

Gene expression in normal tissue: HAL

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in HAL


DatabasePathway IDPathway Des.
wikipathwaysWP3925Amino Acid metabolism
smpdbSMP00009Ammonia Recycling
smpdbSMP00044Histidine Metabolism
smpdbSMP00191Histidinemia
kegghsa00340Histidine metabolism - Homo sapiens (human)
humancycPWY-5030histidine degradation
reactomeR-HSA-1430728Metabolism
reactomeR-HSA-6788656Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism
reactomeR-HSA-70921Histidine catabolism
reactomeR-HSA-71291Metabolism of amino acids and derivatives

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD353PD03259011

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in HAL

​​​​